Avadel Pharmaceuticals Announces Restructuring to Focus on FT218 Clinical Development Program – GlobeNewswire

– Company cost structure expected to be reduced by $70 to $75 million in 2019 – Approximately $100 million in cash and marketable securities at December 31, 2018 DUBLIN, Ireland, Feb. 07, 2019 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), today announced a corporate restructuring to assure the financial health required to maximize the…

RBI allows companies participating in insolvency process to tap ECB route – Business Today

In a bid to facilitate resolution process under insolvency law, the RBI Thursday proposed to permit bidders to raise funds through external commercial borrowing for repayment to the existing lenders. As per the existing guidelines, the proceeds of External Commercial Borrowing (ECB) denominated in either foreign currency or Indian Rupee, are not permitted to be…